Fundación Respirar ( Site 2912)

Buenos Aires, Buenos Aires F.D. C1426AAL

2 studies enrolling now · 2 studies all time

What they study most

Fallopian Tube Cancer, Ovarian Cancer, Ovarian Neoplasms, Primary Peritoneal Cancer

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) — Recruiting now
• A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) — Recruiting now